Latest TRI News
Launch of Phase 3 clinical trial with Nefecon in Japan
STOCKHOLM, July 4, 2024 /PRNewswire/ -- Calliditas Therapeutics AB (NASDAQ: CALT) (NASDAQ…
Metabolon reçoit une subvention des NIH pour développer des outils avancés de surveillance et de prédiction de l’évolution du diabète de type 1
MORRISVILLE, Caroline du Nord, 26 juin 2024 /PRNewswire/ -- Metabolon, Inc, leader mondial…
Micro Medical Solutions Achieves Milestone with 200th Enrollment in HEAL Registry
Clinical investigators complete record enrollment in real-world Registry, HEAL (An All-comers Registry…
Hansa Biopharma Completes Randomization in Pivotal Phase 3 US ConfIdeS Trial
LUND, Sweden, May 31, 2024 /PRNewswire/ -- Hansa Biopharma AB, ("Hansa" or…
Valcare Medical Announces Enrollment of First Two Patients in AMEND™ TS EU Pilot Study
TAMPA, Fla., May 14, 2024 /PRNewswire/ -- Valcare Medical, Inc., a leading…
Replicate Bioscience Presents Positive Data from Phase 1 Trial and Preclinical Data with Novel Self-Replicating RNA at the 2024 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
Positive data from Phase 1 trial of RBI-4000 vaccine achieve WHO-established surrogate…
TAR-210 results show 90% recurrence-free survival and 90% complete response in patients with high-risk and intermediate-risk non-muscle-invasive bladder cancer, respectively
Updated results reinforce the potential of TAR-210 to transform treatment of non–muscle-invasive…
